New Drugs
| Brand/Generic | Company | Description |
|---|---|---|
|
Artesunate artesunate |
Amivas | An injectable antimalarial for treatment of severe malaria. |
|
Ayvakit avapritinib Click here for more information |
Blueprint Medicines | A kinase inhibitor for advanced gastrointestinal stromal tumor (GIST). |
|
Bafiertam monomethyl fumarate Click here for more information |
Banner Life Sciences | The active metabolite of dimethyl fumarate for multiple sclerosis. |
|
Barhemsys amisulpride Click here for more information |
Acacia Pharma | A dopamine-2 antagonist for prevention and treatment of postop nausea and vomiting. |
|
Byfavo remimazolam Click here for more information |
Acacia Pharma | An injectable benzodiazepine for induction and maintenance of procedural sedation. |
|
Cerianna fluoroestradiol F 18 Click here for more information |
Zionexa | A radioactive diagnostic agent for PET imaging to detect estrogen receptor-positive lesions in patients with breast cancer. |
|
Darzalex Faspro daratumumab/ hyaluronidase-fihj Click here for more information |
Janssen Biotech | Combination monoclonal antibody and hyaluronidase for multiple myeloma. |
|
Dojolvi triheptanoin Click here for more information |
Ultragenyx Pharm. | A medium-chain triglyceride oral liquid for patients with long-chain fatty acid oxidation disorders. |
|
Hulio adalimumab-fkjp Click here for more information |
Mylan | A biosimilar to Humira. |
|
Inqovi decitabine/cedazuridine Click here for more information |
Taiho Oncology | A combination drug for myelodysplastic syndromes. |
|
Isturisa osilodrostat Click here for more information |
Recordati Rare Diseases | A cortisol synthesis inhibitor for Cushing’s disease. |
|
Koselugo selumetinib Click here for more information |
AstraZeneca | A kinase inhibitor for pediatric neurofibromatosis type 1. |
|
Lyumjev insulin lispro-aabc Click here for more information |
Lilly | New rapid-acting insulin analog for diabetes. |
|
Nexletol bempedoic acid Click here for more information |
Esperion | An adenosine triphosphate-citrate lyase inhibitor for hypercholesterolemia. |
|
Nexlizet bempedoic acid/ezetimibe Click here for more information |
Esperion | An adenosine triphosphate-citrate lyase inhibitor and cholesterol absorption inhibitor for hypercholesterolemia. |
|
Nurtec ODT rimegepant Click here for more information |
Biohaven Pharm. | A calcitonin gene-related peptide receptor antagonist for acute treatment of migraine. |
|
Nyvepria pegfilgrastim-apgf Click here for more information |
Pfizer | A biosimilar to Neulasta. |
|
Ongentys opicapone Click here for more information |
Neurocrine Biosciences | A COMT inhibitor for Parkinson’s disease patients experiencing “off” episodes. |
|
Palforzia peanut (Arachis hypogaea) allergen powder-dnfp |
Aimmune Therapeutics | An oral immunotherapy for patients with peanut allergy. |
|
Pemazyre pemigatinib Click here for more information |
Incyte Corp. | A kinase inhibitor for advanced cholangiocarcinoma. |
|
Phesgo pertuzumab/trastuzumab/hyaluronidase-zzxf Click here for more information |
Genentech | Monoclonal antibodies for HER2-positive breast cancer. |
|
Pizensy lactitol Click here for more information |
Braintree Labs | An osmotic laxative for chronic idiopathic constipation. |
|
Qinlock ripretinib Click here for more information |
Deciphera Pharm. | A kinase inhibitor for advanced gastrointestinal stromal tumor (GIST). |
|
QWO collagenase clostridium histolyticum-aaes Click here for more information |
Endo Pharm. | Combination bacterial collagenases for moderate to severe cellulite in the buttocks of women. |
|
Retevmo selpercatinib Click here for more information |
Lilly | A kinase inhibitor for metastatic non-small cell lung cancer and medullary thyroid cancer. |
|
Rukobia fostemsavir Click here for more information |
ViiV Healthcare | A new antiretroviral for multidrug-resistant HIV-1 infection. |
|
Sarclisa isatuximab-irfc Click here for more information |
Sanofi-Aventis U.S. | A monoclonal antibody for multiple myeloma. |
|
Semglee insulin glargine Click here for more information |
Mylan | A new long-acting insulin for diabetes. |
|
Sevenfact factor VIIa (recombinant)-jncw Click here for more information |
HEMA Biologics | A coagulation factor to control bleeding episodes in patients with hemophilia A or B with inhibitors (neutralizing antibodies). |
|
Tabrecta capmatinib Click here for more information |
Novartis Pharm. | A kinase inhibitor for metastatic non-small cell lung cancer. |
|
Tauvid flortaucipir F 18 Click here for more information |
Lilly | A radioactive diagnostic agent for PET imaging of the brain for patients being evaluated for Alzheimer’s disease. |
|
Tazverik tazemetostat Click here for more information |
Epizyme | A methyltransferase inhibitor for advanced epithelioid sarcoma and follicular lymphoma. |
|
Tepezza teprotumumab-trbw Click here for more information |
Horizon | A monoclonal antibody for thyroid eye disease. |
|
Trodelvy sacituzumab govitecan-hziy Click here for more information |
Immunomedics | A monoclonal antibody for metastatic breast cancer. |
|
Tukysa tucatinib Click here for more information |
Seattle Genetics | A kinase inhibitor for advanced breast cancer. |
|
Uplizna inebilizumab-cdon Click here for more information |
Viela Bio | A monoclonal antibody for neuromyelitis optica spectrum disorder. |
|
Vyepti eptinezumab-jjmr Click here for more information |
Lundbeck | A calcitonin gene-related peptide antagonist for prevention of migraine. |
|
Zeposia ozanimod Click here for more information |
Celgene | An oral sphingosine 1-phosphate receptor modulator for relapsing forms of multiple sclerosis. |
|
Zepzelca lurbinectedin Click here for more information |
Jazz Pharm. | An alkylating drug for metastatic small cell lung cancer. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Anjeso meloxicam Click here for more information |
Baudax Bio | An injectable NSAID for moderate to severe pain. |
|
Bynfezia Pen octreotide Click here for more information |
Sun Pharm. | New subcutaneous pen formulation for patients with acromegaly, carcinoid tumors, or vasoactive intestinal peptide tumors. |
|
Durysta bimatoprost implant Click here for more information |
Allergan | An implant formulation for reduction of intraocular pressure in patients with open angle glaucoma or ocular hypertension. |
|
Elyxyb celecoxib Click here for more information |
Promius Pharma | New oral solution formulation for treatment of acute migraine. |
|
Fensolvi leuprolide Click here for more information |
Tolmar Pharm. | New injectable formulation for pediatric patients with central precocious puberty. |
|
Fintepla fenfluramine Click here for more information |
Zogenix | New oral solution formulation for seizures associated with Dravet syndrome. |
|
Gimoti metoclopramide Click here for more information |
Evoke Pharma | New nasal spray formulation for diabetic gastroparesis. |
|
Impeklo clobetasol propionate Click here for more information |
Mylan | New lotion formulation for corticosteroid-responsive dermatoses. |
|
Jelmyto mitomycin Click here for more information |
UroGen Pharma | New formulation for pyelocalyceal use for upper tract urothelial cancer. |
|
Kynmobi apomorphine Click here for more information |
Sunovion Pharm. | A sublingual film formulation for intermittent treatment of “off” episodes in Parkinson’s disease. |
|
Milprosa progesterone Click here for more information |
Ferring Pharm. | A progesterone-containing vaginal insert to support embryo implantation and early pregnancy. |
|
Monoferric ferric derisomaltose Click here for more information |
Pharmacosmos | An intravenous iron replacement formulation for iron deficiency anemia. |
|
Mycapssa octreotide Click here for more information |
Chiasma | New oral capsule formulation for long-term maintenance treatment of acromegaly. |
|
Oriahnn elagolix/estradiol/norethindrone Click here for more information |
AbbVie | A combination oral GnRH antagonist, estrogen, and progestin for fibroid-associated heavy menstrual bleeding in premenopausal women. |
|
Phexxi lactic acid/citric acid/potassium bitartrate Click here for more information |
Evofem | A vaginal gel formulation for on-demand prevention of pregnancy. |
|
Procysbi cysteamine bitartrate Click here for more information |
Horizon Therapeutics | New delayed-release capsules and oral granules for nephropathic cystinosis. |
|
Tivicay PD dolutegravir Click here for more information |
ViiV Healthcare | New tablets for oral suspension formulation. |
|
Trijardy XR empagliflozin/linagliptin/metformin Click here for more information |
Boehringer Ingelheim | New combination formulation for glycemic control in patients with type 2 diabetes. |
|
Twirla levonorgestrel/ethinyl estradiol Click here for more information |
Agile Therapeutics | New estrogen/progestin contraceptive patch. |
|
Upneeq oxymetazoline Click here for more information |
RVL Pharm. | A 0.1% ophthalmic solution for acquired blepharoptosis. |
|
Valtoco diazepam nasal spray Click here for more information |
Neurelis | New nasal spray formulation for acute treatment of seizure clusters and acute repetitive seizures. |
|
Zilxi minocycline Click here for more information |
Foamix Pharm. | A topical foam formulation for rosacea. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Belviq, Belviq XR lorcaserin Click here for more information |
Eisai | Voluntary withdrawal from the market due to concerns about an increased occurrence of cancer seen in a clinical trial. |
|
Zantac (and generics) ranitidine Click here for more information |
Multiple | Withdrawal of all products (prescription and OTC) from the market due to safety concerns of the contaminant NDMA found in ranitidine products. |